Stock 300534 GANSU LONGSHENRONGFA PHARMACEUTICAL INDUSTRY CO.,LTD
Add to a list
To use this feature you must be a member
Log inSign up

All News Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD

Equities

300534

CNE100002CP5

End-of-day quote Shenzhen S.E.
Other stock markets
 18:00:00 2024-06-23 EDT 		5-day change 1st Jan Change
6.97 CNY -4.52% Intraday chart for Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD -4.39% -29.38%
05-30 Gansu Longshenrongfa Pharmaceutical Industry Co.,Ltd Announces Final Cash Dividend for 2023, Payable on 06 June 2024 CI
05-17 Longshenrongfa Pharmaceutical Appoints Vice Chairman, Deputy General Manager MT

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Gansu Longshenrongfa Pharmaceutical Industry Co.,Ltd Announces Final Cash Dividend for 2023, Payable on 06 June 2024
CI
Longshenrongfa Pharmaceutical Appoints Vice Chairman, Deputy General Manager
MT
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD Proposes Final Cash Dividend for 2023
CI
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD cancelled the transaction announced on July 17, 2023
CI
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Longshenrongfa Pharmaceutical Renews Food Production License
MT
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD announced that it expects to receive CNY 485.796067 million in funding from Gansu Pharmaceutical Investment Group Co., Ltd., Gansu Great Wall Xinglong Silk Road Fund Management Co., Ltd. and other investors.
CI
An unknown buyer agreed to acquire 7.1% stake in Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD for CNY 234.5 million.
CI
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Chinese Shares Rebound; Longshenrongfa Pharma Rises 3.9% on Renewal of Drug Production License
MT
Gansu Longshenrongfa Pharma Renews Drug Production License
MT
Drug Regulator Approves Changes to Longshenrongfa Pharma's Drug Production License
MT
Longshenrongfa Pharma Gets Nod for Proposed Changes in License
MT
Gansu Longshenrongfa Pharmaceutical Industry Co.,Ltd completed the acquisition of 70% stake in Gansu Pu'an Pharmaceutical Co.,Ltd. from Gansu Province Farms Agribusiness Ref co Group Ltd.
CI
Longshenrongfa Pharma Gets Provincial Regulator's Nod for Cough Capsules
MT
Gansu Longshenrongfa Leases Properties to Affiliates
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 300534 Stock
  4. News Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD